Related Experiment Video
Updated: Aug 28, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
A global view of hypertensive disorders and diabetes mellitus during pregnancy
Li Jiang1, Kun Tang1,2, Laura A Magee3
1Centre for Global Child Health, The Hospital for Sick Children, Toronto, Canada.
Insights
Maternal cardiometabolic disorders like hypertensive disorders in pregnancy (HDP) and gestational diabetes mellitus (GDM) disproportionately affect low-income regions. Addressing these conditions requires a multilevel approach beyond individual care to combat health inequities.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Endocrinology
- Public Health
Background:
- Maternal cardiometabolic disorders (CMDs), including hypertensive disorders in pregnancy (HDP) and gestational diabetes mellitus (GDM), represent a significant global health burden.
- Lack of standardized diagnostic criteria for HDP and GDM complicates accurate assessment of disease burden across diverse regions.
- These disorders disproportionately impact low- and middle-income countries (LMICs) and populations with lower sociodemographic and human development indexes.
Purpose of the Study:
- To highlight the global disease burden of maternal cardiometabolic disorders (CMDs).
- To emphasize the influence of social determinants of health and systemic marginalization on maternal CMDs.
- To advocate for a multilevel approach and multisectoral partnerships to address health inequities related to maternal CMDs.
Main Methods:
- Review of existing literature on the epidemiology and management of HDP and GDM.
- Analysis of the impact of social determinants of health on maternal CMDs.
- Discussion of current challenges in screening and management, including disruptions from the COVID-19 pandemic.
Main Results:
- Maternal CMDs exhibit an uneven disease burden, particularly in LMICs.
- Social determinants of health significantly influence the development and consequences of maternal CMDs.
- The accuracy and long-term effects of screening and management programs require further investigation.
Conclusions:
- A comprehensive, multilevel strategy involving multisectoral partnerships is essential to address the public health issues and health inequities stemming from maternal CMDs.
- Women with maternal CMDs are particularly vulnerable during public health crises like the COVID-19 pandemic.
- Further research is needed to refine screening and management protocols for HDP and GDM.
Abstract:
Two important maternal cardiometabolic disorders (CMDs), hypertensive disorders in pregnancy (HDP) (including pre-eclampsia) and gestational diabetes mellitus (GDM), result in a large disease burden for pregnant individuals worldwide. A global consensus has not been reached about the diagnostic criteria for HDP and GDM, making it challenging to assess differences in their disease burden between countries and areas. However, both diseases show an unevenly distributed disease burden for regions with a low income or middle income, or low-income and middle-income countries (LMICs), or regions with lower sociodemographic and human development indexes. In addition to many common clinical, demographic and behavioural risk factors, the development and clinical consequences of maternal CMDs are substantially influenced by the social determinants of health, such as systemic marginalization. Although progress has been occurring in the early screening and management of HDP and GDM, the accuracy and long-term effects of such screening and management programmes are still under investigation. In addition to pharmacological therapies and lifestyle modifications at the individual level, a multilevel approach in conjunction with multisector partnership should be adopted to tackle the public health issues and health inequity resulting from maternal CMDs. The current COVID-19 pandemic has disrupted health service delivery, with women with maternal CMDs being particularly vulnerable to this public health crisis.
More Related Videos
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypertension II: Pathophysiology